新聞BELLUS Health Inc. attends event Invest Canada '25.At Invest Canada '25, Export Development Canada hosted a VC-focused breakout featuring executives from Clutch Technologies, Solium Capital, and Bellus Health who have each played a central role in building or leading Canadian growth stories.
新聞BELLUS Health Inc. merges with GlaxoSmithKline.BELLUS Health has agreed to merge with GSK Plc.
新聞GlaxoSmithKline acquired BELLUS Health Inc. for $2B on Apr 25th '23.GSK plc (LSE/NYSE: GSK) and BELLUS Health Inc. (TSX/NASDAQ: BLU) today announced that they have entered into an agreement under which GSK will acquire BELLUS, a Canada-based, late-stage biopharmaceutical company working to better the lives of patients suffering from refractory chronic cough (RCC) for US$14.75 per share of common stock in cash representing an approximate total equity value of US$2.0 billion (£1.6 billion).
